Neurodevelopmental Outcomes after Premedication with Atropine/Propofol vs Atropine/Atracurium/Sufentanil for Neonatal Intubation: 2-Year Follow-Up of a Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 33301785.
- Also identified by DOI 10.1016/j.jpeds.2020.12.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study followed 173 newborn infants in the PREmedication Trial for Tracheal Intubation of the NEOnate multicenter, double-blind, randomized controlled trial of atropine-propofol vs atropine-atracurium-sufentanil for premedication before nonemergency intubation. At 2 years of corrected age, there was no significant difference between the groups in death or risk of neurodevelopmental delay assessed with the Ages and Stages Questionnaire. Trial registration Clinicaltrials.gov: NCT01490580.
Medical subject headings
- Adjuvants, Anesthesia
- Anesthetics, Combined
- Atracurium
- Atropine
- Intubation, Intratracheal
- Nervous System
- Propofol
- Sufentanil